Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 22;5(1):1.
doi: 10.3390/microarrays5010001.

SNP Array in Hematopoietic Neoplasms: A Review

Jinming Song  1 , Haipeng Shao  2
Affiliations
Review

SNP Array in Hematopoietic Neoplasms: A Review

Jinming Song et al. Microarrays (Basel). .

Abstract

Cytogenetic analysis is essential for the diagnosis and prognosis of hematopoietic neoplasms in current clinical practice. Many hematopoietic malignancies are characterized by structural chromosomal abnormalities such as specific translocations, inversions, deletions and/or numerical abnormalities that can be identified by karyotype analysis or fluorescence in situ hybridization (FISH) studies. Single nucleotide polymorphism (SNP) arrays offer high-resolution identification of copy number variants (CNVs) and acquired copy-neutral loss of heterozygosity (LOH)/uniparental disomy (UPD) that are usually not identifiable by conventional cytogenetic analysis and FISH studies. As a result, SNP arrays have been increasingly applied to hematopoietic neoplasms to search for clinically-significant genetic abnormalities. A large numbers of CNVs and UPDs have been identified in a variety of hematopoietic neoplasms. CNVs detected by SNP array in some hematopoietic neoplasms are of prognostic significance. A few specific genes in the affected regions have been implicated in the pathogenesis and may be the targets for specific therapeutic agents in the future. In this review, we summarize the current findings of application of SNP arrays in a variety of hematopoietic malignancies with an emphasis on the clinically significant genetic variants.

Keywords: SNP array; hematopoietic; leukemia; lymphoma; myelodysplastic syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed application of SNP array in hematopoietic malignancies.
See this image and copyright information in PMC

References

    1. Hahn W.C., Weinberg R.A. Rules for making human tumor cells. N. Engl. J. Med. 2002;347:1593–1603. doi: 10.1056/NEJMra021902. - DOI - PubMed
    1. Bayani J.S.J. Traditional banding of chromosomes for cytogenetic analysis. Curr. Protoc. Cell Biol. 2004:S23. doi: 10.1002/0471143030.cb2203s23. - DOI - PubMed
    1. Levsky J.M., Singer R.H. Fluorescence in situ hybridization: Past, present and future. J. Cell Sci. 2003;116:2833–2838. doi: 10.1242/jcs.00633. - DOI - PubMed
    1. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818–821. doi: 10.1126/science.1359641. - DOI - PubMed
    1. Du Manoir S., Speicher M.R., Joos S., Schrock E., Popp S., Dohner H., Kovacs G., Robert-Nicoud M., Lichter P., Cremer T. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum. Genet. 1993;90:590–610. doi: 10.1007/BF00202476. - DOI - PubMed

LinkOut - more resources